Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue
Introduction: Mesenchymal stromal cells are a heterogeneous cell population that is characterized by multiple functional properties including the ability to secrete paracrine factors,[8] regulate immune effector cells,[9][10] maintain primitive phenotypes of other cell populations[11][12] and support tissue regeneration.[13][14] Mesenchymal stromal cells can contain a sub-population of stem or progenitor cells that demonstrate in vitro self-renewal and differentiation, as has been rigorously demonstrated for umbilical cord-derived progenitor cells.[15] Mesenchymal stromal cells and mesenchymal stem cells are both abbreviated as “MSCs”.[16] For the purpose of this document, the abbreviated term “MSCs” refers to mesenchymal stromal cells. The functional definition of MSCs has evolved over time as the biology of these cells is better understood. Despite these advances, substantial ambiguities persist regarding the nomenclature, nature, identity, function, mode of isolation and experimental handling of these cells. MSCs are not fully defined by the initial minimal criteria[17] proposed by the International Society of Cell and Gene Therapy (ISCT), and as such require careful characterization by a matrix of functional assays.[16] MSCs have been isolated from umbilical cord[15], bone marrow[18][19] and other tissue sources, and are widely used for non-clinical research. MSCs from different tissue sources have different properties. Different institutions use different practices for isolating, proc
Scope: This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from umbilical cord tissue (i.e. Wharton’s jelly), further referred to as hUC-MSCs, including the collection of umbilical cord tissue and associated data, isolation, culture characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport. This document is applicable to all organizations performing biobanking of hUC-MSCs used for research and development. This document does not apply to hUC-MSCs for the purpose of in vivo application in humans, clinical applications or therapeutic use. NOTE International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.